Drepanocitosis y planificación familiar / Sickle cell disease and family planning

Introducción: La planificación familiar en las gestantes con drepanocitosis contribuye a disminuir el número de embarazos y la morbimortalidad materno fetal. Objetivo: Analizar conceptos de planificación familiar aplicables a la gestante con drepanocitosis y proponer acciones de asesoramiento encaminadas a disminuir los indicadores de morbilidad y mortalidad materna y fetal relacionadas con esta enfermedad. Métodos: Se realizó una revisión de la literatura, en inglés y español, a través del sitio web Pubmed y el motor de búsqueda Google académico de artículos publicados en los últimos 5 años, con análisis y resumen de la bibliografía revisada. Análisis y síntesis de la información: La gran mayoría de las pacientes con drepanocitosis desconocen los conceptos de salud sexual y reproductiva, así como de planificación familiar, por lo que muchas se convierten en mujeres con múltiples gestaciones que terminan en abortos, con alto riesgo de complicaciones severas y 2,5 veces más posibilidades de muerte durante la gestación y el puerperio que una gestante no enferma. La aplicación de un grupo de medidas encaminadas a dar a conocer estos conceptos desde la consulta de hematología, acercan a estas pacientes y a su pareja a la toma correcta de decisión sobre en qué momentos y cuántos hijos tener. Conclusión: La planificación familiar como proceso de atención médica en la drepanocitosis, con participación directa del hematólogo, como médico de asistencia primario durante toda la vida de estas gestantes, contribuye a fortalecer la relación entre el trabajo del equipo asistencial, la pareja y disminuye la morbilidad y mortalidad materna fetal(AU)

Introduction: Family planning in pregnant women with sickle cell disease contributes to reducing the number of pregnancies and maternal-fetal morbidity and mortality. Objective: To analyze family planning concepts applicable to pregnant women with sickle cell disease and propose counseling actions aimed at reducing the indicators of maternal fetal morbidity and mortality related to this disease. Methods: A literature review was carried out, in English and Spanish, through the Pubmed website and the academic Google search engine of articles published in the last 5 years, with analysis and summary of the reviewed bibliography. Analysis and synthesis of information: The vast majority of patients with sickle cell disease are unaware of the concepts of sexual and reproductive health as well as FP, so many become women with multiple pregnancies that end in abortions, with a high risk of complications severe and 2.5 times more likely to die during pregnancy and the puerperium than a non-ill pregnant woman. The application of a group of measures aimed at making these concepts known from the hematology consultation, brings these patients and their partner closer to making the correct decision about when and how many children to have. Conclusion: Family planning as a medical care process in sickle cell disease, with direct participation of the hematologist, as primary care physician throughout the life of these pregnant women, contributes to strengthening the relationship between the work of the healthcare team, the couple and decreases morbidity and fetal maternal mortality(AU)

[Outcomes of radical prostatectomy in patients with prostate cancer at the Aristide Le Dantec University Hospital]. / La prostatectomie radicale: résultats carcinologiques au Centre Hospitalier Universitaire Aristide Le Dantec.

The purpose of this study was to assess outcomes of radical prostatectomy in patients with prostate cancer. We conducted a retrospective single-center study in the Department of Urology and Andrology at the Aristide Le Dantec Hospital in Dakar from June 1, 2010 to May 31, 2016. We collected data of 60 patients undergoing radical retropubic prostatectomy associated with dissection of the iliac and obturator nodes. After radical prostatectomy, prostate specific antigen (PSA) levels were undetectable (<0.1 ng/mL) in 20 patients (33.3%). Eleven patients (18.3%), who had biochemical relapse, received complementary hormone therapy. Patients achieved a response after initiation of treatment, and total PSA became undetectable again after an 8-month follow-up period. Mean overall survival was 17.5 months, with a median of 9.49. Cumulative overall survival rates at 1 year, 3 years and 4 years were 42.4, 13.6 and 6.8%, respectively. Mean relapse-free survival was 17.3 months, with a median biochemical relapse-free survival of eleven (11) months. The mean duration of specific survival was 8.1 months, with a median of 3 months. Seven patients had positive resection margins (11.6%). Four patients had lymph node involvement. Radical prostatectomy, suggested in some patients with prostate cancer in our practice, has been shown to be an effective therapeutic method leading to good outcomes.

Primary squamous cell carcinoma of the kidney in southern Senegal (Ziguinchor): case report and review of the literature.

The kidney's primary squamous cell carcinoma is a rare tumor, representing 0.5-0.8% of malignant renal tumors and 4% of upper urinary tract tumors. This pathology often occurs after a long past history of renal lithiasis and repeated untreated or poorly treated urinary tract infections. The delay in diagnosis resulting from an insidious symptomatology, without specific signs, often leads to a pejorative development, especially in poor countries. A seventy-nine-year-old Senegalese woman, with no past history of lithiasis nor recurrent urinary tract infection and urinary schistosomiasis, was received for a recurrent total hematuria associated with left lumbar pain. Clinical examination revealed a mobile tender left lumbar mass, with lumbar contact and renal sloshing. The left renal tumor´s diagnosis was retained on clinical and scannographic arguments, justifying an enlarged left total nephrectomy, by laparotomy. The anatomopathological examination of the surgical sample made it possible to make the diagnosis of primary invasive squamous cell carcinoma of the left kidney and to find foci of carcinoma in-situ on squamous metaplasia in the calyxes. Unlike the typical case of primary squamous cell carcinoma of the kidney, our patient did not have a long past history of renal lithiasis nor untreated or poorly treated recurrent urinary tract infections and urinary schistosomiasis. Primary squamous cell carcinoma of the kidney may not be related to a past history of recurrent urinary tract infections and lithiasis, but to any other cause of squamous metaplasia of the urothelium. Surgery remains the best option for this entity.